| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |